Tag: paltusotine
Crinetics Pharmaceuticals Announces Pricing of Public Offering of Common Stock
SAN DIEGO, April 07, 2021 (GLOBE NEWSWIRE) -- Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX), a clinical-stage pharmaceutical company focused on the discovery,...